UAB Thermo Fisher Scientific Baltics

UAB „Thermo Fisher Scientific Baltics“ is a Lithuania-based life sciences manufacturing and R&D company, part of Thermo Fisher Scientific Inc.—a global leader in serving science. The Vilnius site is one of Thermo Fisher’s key European hubs for molecular biology reagents and components used in research, diagnostics, and biopharmaceutical production.

Company Overview

Legal name: UAB „Thermo Fisher Scientific Baltics“
Industry: Biotechnology; Life Sciences; Pharmaceuticals supply and diagnostics components
Founded: Origin dates to the legacy company Fermentas (established in the late 1970s as a biochemistry and enzyme research/manufacturing organization in Vilnius; reorganized into a modern corporate entity in the 1990s). Fermentas was acquired by Thermo Fisher Scientific in 2010; the Lithuanian operations later adopted the Thermo Fisher Scientific Baltics name.
Headquarters: Vilnius, Lithuania

Legal Information

Įmonės kodas (company registration code): Not publicly verifiable in this environment. Typically available via Lithuania’s Register of Legal Entities (Registrų centras) or Rekvizitai.lt.
PVM kodas (VAT code): Not publicly verifiable in this environment. Usually listed on Rekvizitai.lt and VIES (VAT Information Exchange System).
Registered office address: V. A. Graičiūno g. 8, LT-02241 Vilnius, Lithuania
Official website: https://www.thermofisher.com
Corporate contact email (general): info@thermofisher.com (Note: The company uses web forms and regional mailboxes; a site-specific mailbox for Vilnius is not publicly listed on the global website.)
Registered office phone: Not publicly listed on the global website. Contact is typically via Thermo Fisher’s online contact forms and customer service numbers.

Note: Lithuanian-specific legal registration details (įmonės kodas and PVM kodas) are standard for UAB entities but require confirmation from official registries. Users seeking the exact codes should consult Registrų centras or Rekvizitai.lt.

Business Operations

Main products and services:
- Molecular biology reagents: restriction enzymes, DNA/RNA modifying enzymes, polymerases (PCR/qPCR), ligases, endonucleases, reverse transcriptases, and related buffers/kits.
- Nucleic acid analysis and preparation: DNA ladders/markers, cloning and library preparation kits, components for next-generation sequencing workflows.
- Diagnostic and OEM components: enzymes and reagents supplied to IVD manufacturers for PCR-based and other molecular diagnostics.
- Protein research reagents and tools.
- R&D and quality systems supporting high-volume, high-quality bioreagent manufacturing.

Business model: B2B manufacturing and global distribution. Products are marketed under Thermo Fisher’s brands (Thermo Scientific, Applied Biosystems, Invitrogen) and delivered via Thermo Fisher’s e-commerce channels, regional customer care teams, and OEM partnerships with diagnostics and biopharma companies.

Market position: The Vilnius site is one of the largest life-science manufacturing centers in the Baltics and a significant European producer of molecular biology reagents. It supplies global research, clinical diagnostics, and bioprocessing markets through Thermo Fisher’s international network.

History

Legacy: The Lithuanian operations originated from Fermentas, a Vilnius-based biochemistry and enzyme enterprise that developed a worldwide reputation in restriction enzymes and molecular biology tools.

Key milestones:
- Late 1970s–1990s: Fermentas builds strong international presence in molecular biology reagents from Vilnius.
- 1990s: Corporate modernization and expansion of export markets.
- 2010: Thermo Fisher Scientific Inc. acquires Fermentas, integrating it into its global Life Sciences Solutions segment (widely reported in industry press and Thermo Fisher releases).
- 2010s: Rebranding in Lithuania to Thermo Fisher Scientific Baltics; steady capacity expansions and modernization of production and QA/QC systems.
- 2020–2022: Significant ramp-up to support global demand for PCR and other molecular biology components during the COVID-19 pandemic; continued investment in facilities and talent in Vilnius.
- 2020s: Ongoing expansions to support NGS workflows, OEM supply, and advanced bioprocessing reagents, strengthening Lithuania’s position as a European life sciences hub.

Financial Information

Ownership structure: Wholly-owned subsidiary of Thermo Fisher Scientific Inc. (NYSE: TMO). The Lithuanian entity operates as part of Thermo Fisher’s Life Sciences Solutions and related business segments.

Revenue: Company-level, audited revenue figures for the Lithuanian entity are not published in Thermo Fisher’s consolidated reports. Local revenue data may be available via Lithuanian corporate registries or business directories (e.g., Rekvizitai.lt, Creditinfo) but are not directly accessible in this environment. Public reporting and news coverage indicate notable revenue growth during 2020–2022 due to elevated demand for PCR and molecular diagnostics components.

Funding rounds: Not applicable; the company is a subsidiary of Thermo Fisher Scientific Inc. and funds expansions internally through corporate resources.

Leadership and Management

Structure: The Vilnius site is led by local executives and senior managers within Thermo Fisher’s global organizational framework. The statutory manager (vadovas) and board details for the Lithuanian UAB are maintained in Lithuania’s Register of Legal Entities.

Key executives (vadovai): Specific full names and titles are not publicly listed on the global website and could not be verified here. Historically, the site leadership includes a General Manager/Managing Director, heads of Manufacturing, R&D, Quality, and Supply Chain, integrated with Thermo Fisher’s global Life Sciences Solutions leadership.

Note: For exact names and positions, consult Registrų centras or reputable Lithuanian business directories (e.g., Rekvizitai.lt), which list the current statutory manager and, where applicable, supervisory board members.

Office Locations

Primary campus and manufacturing site:
- Address: V. A. Graičiūno g. 8, LT-02241 Vilnius, Lithuania
- Phone: Not openly published on the global website; contact typically via Thermo Fisher online forms or regional customer service.

Note: If additional offices or satellite facilities exist in Lithuania, they are not clearly enumerated on the global site. The Vilnius campus is the principal site. Up-to-date location details can be confirmed via the company’s careers pages, local media, and official registries.

Market Position

Competitors: New England Biolabs (NEB); Qiagen; Merck KGaA (MilliporeSigma/Sigma-Aldrich); Bio-Rad Laboratories; Agilent Technologies; and other regional and specialized producers of enzymes and molecular biology reagents.

Competitive advantages:
- Integration into Thermo Fisher’s global supply chain, quality systems, and brand portfolio (Thermo Scientific, Applied Biosystems, Invitrogen).
- Longstanding expertise in enzyme manufacturing and molecular biology tools developed from the Fermentas legacy.
- Scale and reliability in OEM supply for diagnostics, supported by stringent regulatory compliance and QA/QC.
- Strong R&D collaboration across Thermo Fisher divisions and European scientific networks.

Market share: Not publicly broken out for the Lithuanian entity. Thermo Fisher is among global leaders in life science reagents, and the Vilnius site contributes meaningfully to European supply of molecular biology components.

Recent Developments

- Capacity expansions in Vilnius to support increased global demand for PCR/qPCR reagents and related components during and after the COVID-19 pandemic (2020–2022).
- Ongoing investment in talent development, quality systems, and manufacturing technologies to support advanced molecular biology, NGS workflows, and OEM diagnostics supply in the 2020s.
- Continued recognition of Lithuania as a strategic life sciences hub, with Thermo Fisher’s Vilnius site highlighted by national investment agencies and media for its contribution to exports and high-skilled employment.

Note: Specific project announcements, dates, and figures vary by press release and local coverage; users seeking detailed updates should review Thermo Fisher’s newsroom and Lithuanian business media.

Contact Information

Registered office (Vilnius):
V. A. Graičiūno g. 8, LT-02241 Vilnius, Lithuania
Phone: Not publicly listed on the global site
Email: info@thermofisher.com
Website: https://www.thermofisher.com

Customer service and inquiries:
Thermo Fisher provides country/region-specific customer service via its website (Contact Us pages), including web forms and regional phone numbers. A Lithuania-specific phone/email is not directly published on the global site in this environment.

Sources and References

- Thermo Fisher Scientific Inc. official website (Company overview, products, brands; general contact information): thermofisher.com
- Thermo Fisher Scientific press releases and investor communications (2010 acquisition of Fermentas; global operations context).
- Invest Lithuania and Lithuanian business media (features on life sciences sector growth and Thermo Fisher’s role in Vilnius).
- Rekvizitai.lt and Lithuania’s Register of Legal Entities (legal details such as įmonės kodas, PVM kodas, statutory manager; exact codes should be verified directly in these registries).
- Industry trade media covering molecular biology reagents, OEM diagnostics supply, and competitor landscape (Qiagen, NEB, Merck/MilliporeSigma, Bio-Rad, Agilent).

Disclaimer: Certain legal identifiers (įmonės kodas, PVM kodas), phone numbers, and named executives are not accessible for verification in this environment. For precise legal and contact details, consult official Lithuanian registries (Registrų centras), Rekvizitai.lt, or the company’s local disclosures.